Due to the extremely rare overlap of mitochondrial DNA depletion syndrome type 3 and pediatric hepatocellular carcinoma, the case presents daunting therapeutic challenges.

Bruce Feinberg, DO: Hello, and welcome to this AJMC® Peer Exchange program titled “Oral Therapy Considerations for the Management of Myelodysplastic Syndromes.” I’m Dr Bruce Feinberg, vice president ...

Ryan Haumschild, PharmD, MS, MBA: Hello, and welcome to this AJMC® Peer Exchange program titled “Updates in the Management of Myelodysplastic Syndromes.” I’m Dr Ryan Haumschild, the director of ...

A national prospective study has confirmed a long-suspected link between Agent Orange and a rare but serious form of blood ...

Over the past few decades, advances in hematology have illuminated how a delicate balance between stem cell self-renewal and ...

Myelodysplastic syndrome (MDS) is independently associated with incident cardiovascular disease (CVD), according to a study published online Nov. 10 in the Canadian Journal of Cardiology. Hiroyuki ...

Please provide your email address to receive an email when new articles are posted on . Olutasidenib monotherapy or combination therapy may help certain patients with myelodysplastic syndrome achieve ...

Over the past few decades, advances in hematology have illuminated how a delicate balance between stem cell self-renewal and ...

Company is on track to file the Phase 3 protocol in the fourth quarter of 2025 SAN FRANCISCO, Dec. 15, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that the Office of Orphan ...

Myelodysplastic syndromes, also called myelodysplasia or MDS, is the name for a group of conditions that cause the number of normal blood cells to drop. In these syndromes, the bone marrow does not ...

Findings significant for ischemic heart disease, stroke, heart failure, and atrial fibrillation. (HealthDay News) — Myelodysplastic syndrome (MDS) is independently associated with incident ...